NAFDAC Issues Final Warning on Multi-Dose Malaria Syrups
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a final warning regarding the sale of multi-dose Artemether/Lumefantrine oral suspensions. In a public alert released via its X (formerly Twitter) account (@NafdacAgency) on February 27, 2026, the regulator reminded the public that the registration for these multi-dose dry powders was discontinued…